Paragon Capital Management (Kansas)’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-55,793
| Closed | -$4.45M | – | 53 |
|
|
2024
Q1 | $4.45M | Sell |
55,793
-735
| -1% | -$56.1K | 2.4% | 15 |
|
|
2023
Q4 | $4.46M | Sell |
56,528
-1,654
| -3% | -$118K | 2.53% | 15 |
|
|
2023
Q3 | $4.06M | Sell |
58,182
-512
| -0.9% | -$36.3K | 2.39% | 15 |
|
|
2023
Q2 | $4.06M | Sell |
58,694
-404
| -0.7% | -$28.7K | 2.33% | 16 |
|
|
2023
Q1 | $4.39M | Sell |
59,098
-475
| -0.8% | -$39.8K | 2.66% | 15 |
|
|
2022
Q4 | $5.55M | Sell |
59,573
-773
| -1% | -$74.6K | 3.46% | 12 |
|
|
2022
Q3 | $5.75M | Sell |
60,346
-888
| -1% | -$87.9K | 3.72% | 11 |
|
|
2022
Q2 | $5.67M | Sell |
61,234
-748
| -1% | -$73K | 3.35% | 13 |
|
|
2022
Q1 | $6.27M | Sell |
61,982
-836
| -1% | -$87.8K | 3.2% | 14 |
|
|
2021
Q4 | $6.48M | Sell |
62,818
-2,568
| -4% | -$237K | 3.26% | 12 |
|
|
2021
Q3 | $5.55M | Sell |
65,386
-1,212
| -2% | -$102K | 2.92% | 15 |
|
|
2021
Q2 | $5.56M | Sell |
66,598
-1,567
| -2% | -$128K | 2.77% | 14 |
|
|
2021
Q1 | $5.18M | Sell |
68,165
-2,002
| -3% | -$146K | 2.6% | 14 |
|
|
2020
Q4 | $4.79M | Sell |
70,167
-4,023
| -5% | -$262K | 2.58% | 15 |
|
|
2020
Q3 | $4.33M | Sell |
74,190
-518
| -0.7% | -$32.2K | 2.47% | 15 |
|
|
2020
Q2 | $4.85M | Buy |
74,708
+563
| +0.8% | +$35.5K | 3.05% | 15 |
|
|
2020
Q1 | $4.4M | Sell |
74,145
-3,339
| -4% | -$223K | 3.16% | 15 |
|
|
2019
Q4 | $5.76M | Sell |
77,484
-3,630
| -4% | -$255K | 3.11% | 14 |
|
|
2019
Q3 | $5.12M | Sell |
81,114
-13,723
| -14% | -$813K | 2.68% | 16 |
|
|
2019
Q2 | $5.17M | Buy |
94,837
+4,055
| +4% | +$218K | 2.32% | 18 |
|
|
2019
Q1 | $4.9M | Buy |
90,782
+6,962
| +8% | +$430K | 2.33% | 18 |
|
|
2018
Q4 | $5.49M | Sell |
83,820
-6,464
| -7% | -$483K | 2.96% | 16 |
|
|
2018
Q3 | $7.11M | Sell |
90,284
-31,292
| -26% | -$2.24M | 2.83% | 19 |
|
|
2018
Q2 | $7.82M | Buy |
121,576
+1,592
| +1% | +$105K | 2.55% | 21 |
|
|
2018
Q1 | $7.46M | Sell |
119,984
-1,533
| -1% | -$110K | 2.69% | 19 |
|
|
2017
Q4 | $8.81M | Sell |
121,517
-14,446
| -11% | -$1.05M | 2.9% | 18 |
|
|
2017
Q3 | $11.1M | Sell |
135,963
-5,839
| -4% | -$462K | 3.71% | 12 |
|
|
2017
Q2 | $11.4M | Buy |
141,802
+3,227
| +2% | +$255K | 3.66% | 12 |
|
|
2017
Q1 | $10.9M | Buy |
138,575
+11,889
| +9% | +$949K | 3.41% | 16 |
|
|
2016
Q4 | $10M | Buy |
126,686
+3,446
| +3% | +$279K | 3.32% | 17 |
|
|
2016
Q3 | $11M | Buy |
123,240
+9,383
| +8% | +$886K | 3.71% | 11 |
|
|
2016
Q2 | $10.9M | Buy |
113,857
+1,507
| +1% | +$150K | 3.86% | 10 |
|
|
2016
Q1 | $11.7M | Sell |
112,350
-1,803
| -2% | -$175K | 4.55% | 5 |
|
|
2015
Q4 | $11.2M | Buy |
114,153
+10,214
| +10% | +$1M | 4.32% | 5 |
|
|
2015
Q3 | $10M | Buy |
103,939
+547
| +0.5% | +$57.5K | 3.9% | 8 |
|
|
2015
Q2 | $10.8M | Sell |
103,392
-4,665
| -4% | -$477K | 3.93% | 7 |
|
|
2015
Q1 | $11.2M | Sell |
108,057
-4,191
| -4% | -$424K | 4.16% | 5 |
|
|
2014
Q4 | $10.8M | Sell |
112,248
-3,244
| -3% | -$286K | 3.87% | 8 |
|
|
2014
Q3 | $9.19M | Sell |
115,492
-768
| -0.7% | -$60.5K | 3.53% | 10 |
|
|
2014
Q2 | $8.76M | Sell |
116,260
-1,442
| -1% | -$109K | 3.46% | 10 |
|
|
2014
Q1 | $8.81M | Sell |
117,702
-3,726
| -3% | -$263K | 3.78% | 4 |
|
|
2013
Q4 | $8.69M | Buy |
121,428
+183
| +0.2% | +$11.8K | 4.18% | 3 |
|
|
2013
Q3 | $6.88M | Buy |
121,245
+13,359
| +12% | +$796K | 3.52% | 9 |
|
|
2013
Q2 | $6.17K | Buy |
+107,886
| New | +$6.25M | 3.23% | 12 |
|
Other funds holding CVS
Paragon Capital Management (Kansas)'s CVS Position: Q2 2024 in Review
Paragon Capital Management (Kansas) sold out of CVS Health (CVS) in Q2 2024, closing a stake of 55,793 shares — an estimated $4.45M sold.
Paragon Capital Management (Kansas) first reported a position in CVS in Q2 2013 and held it in 44 quarters. The position peaked at $11.7M in Q1 2016. 1,911 funds tracked by Wall St. Rank hold CVS as of Q2 2024.
- Paragon Capital Management (Kansas) reported no remaining CVS Health position as of Q2 2024 after selling out during the quarter.
- Paragon Capital Management (Kansas) sold 55,793 CVS Health shares in Q2 2024, an estimated $4.45M.
- Paragon Capital Management (Kansas) first reported a position in CVS Health in Q2 2013 and held it in 44 quarters.
- Paragon Capital Management (Kansas)'s CVS Health position peaked at $11.7M in Q1 2016.
- 1,911 funds tracked by Wall St. Rank held CVS Health as of Q2 2024.
Based on Paragon Capital Management (Kansas)'s 13F filing for Q2 2024, filed 12 Aug 2024.